Bowel Cleansing
Conditions
Keywords
LINE, Colonoscopy, Bowel cleansing
Brief summary
This is a prospective, colonoscopist-blinded, randomized, controlled study with consecutive outpatients undergoing colonoscopy in Taipei Medical University Hospital.The study would comply with the standards of the Declaration of Helsinki and current ethical guidelines. It have been approval by Taipei Medical University Institutional Review Board.
Detailed description
Written informed consent will be obtained from all the patients. Patients will be randomized to either the LINE re-education or control group for colon preparation at the time of appointment for colonoscopy by using consecutively numbered envelopes that will contain the treatment assignments, which will be generated by a computer-allocated random digit number, in a 1:1 ratio. At least two LINE accounts for all patients or their relatives living together will be recorded in case of failure to contact. All patients will be instructed not to tell colonoscopists, nurses and investigators before, during and after the procedure about their preparation method and when they receive instructions.
Interventions
BEHAVIORALLINE re-education
Sponsors
Taipei Medical University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)
Masking description
All patients will be instructed not to tell colonoscopists, nurses and investigators before, during and after the procedure about their preparation method and when they receive instructions.
Intervention model description
LINE is a popular application (App) which can share free words, photos, videos and voice messages (http://line.me/en/). LINE is available on all smart phone devices and personal computer. LINE re-education before colonoscopy to confirm optimal bowel cleansing.
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Outpatients aged 18-80 years undergoing colonoscopy who will provide written informed consent will be eligible for participation in the study.
Exclusion criteria
* history of colorectal surgery; * severe colonic stricture or obstructing tumor; * uncooperative mental status; * significant ileus; * known or suspected bowel obstruction or perforation; * severe chronic renal failure (creatinine clearance \<30 ml/min); * severe congestive heart failure (New York Heart Association class III or IV); * uncontrolled hypertension (systolic blood pressure \>180 mm Hg, diastolic blood pressure\>100 mm Hg); * liver cirrhosis; * toxic colitis or megacolon; * active gastrointestinal bleeding; * dehydration or disturbance of electrolytes; * pregnancy or lactation; and * hemodynamically unstable.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adequate bowel preparation | Day 1 | total Ottawa score \<6 or Boston bowel preparation scale ≥ 6 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| colon polyp detection rate | Day 1 | colon polyp detection rate during colonoscopy |
| cecal intubation rate | Day 1 | cecal intubation rate |
Countries
Taiwan
Contacts
Primary ContactWei Yu Kao, M.D.
Outcome results
None listed